DDD North AB © 2012 • Terms of Use

 

 

Focus area are in combined near-infrared spectroscopy and multifrequency bio-impedance investigation of skin alterations in diabetes patients and in suspected malignant melanoma based on multivariate analysis.

 

 

DDD North AB

 Storgatan 54

SE-903 26 Umeå

 Sweden

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

We develope non-invasive derma diagnostic systems

 

Many diseases are reflected in abnormal changes in the skin. Therefore, there is an increasing interest in the development of methods for diagnosing various illnesses by means of non-invasive skin measurements.

 

Near infrared (NIR) spectroscopy and skin impedance (IMP) are two non-invasive skin characterization techniques suggested for the diagnosis and monitoring of various markers of diseases, such as neuropathy and malignant melanoma. We combine the two non-invasive techniques into our instrument DDD-probe.

 

DDD North Ltd will become a profitable and successful company that develops and markets diagnostic tools that increases efficiency, speeds up the appropriate treatment and thereby relieve people's suffering and premature death.

 

The company, owned by CMTF Business Development AB, Umeå are based on patented research results in the field of non-invasive diagnostics.